NCT05847075

Brief Summary

The aim of this study is to compare different non-pharmacological interventions in Type 2 diabetic people, testing their efficiency to improve metabolism and inflammation. The investigators will compare the effects of Heat Therapy (HT) and Strength training (ST), for 12 weeks, to test which one is more effective to improve participants health. Heat Therapy consists in submitting a person to an environmental chamber, initially set at 55 degrees Celsius on three non-consecutive days of the week. Each session will last 60 min. ST consists in supervised exercise in a gym on three non-consecutive days of the week. Each session will last \~60 min and will consist of a warm up, the resistance training and a cool down. All sessions will be conducted by qualified sport and exercise scientists for 12 weeks. A third group of people will stay sedentary without any other intervention for 12 weeks. Before, and after the end of the intervention blood samples will be collected to analyze metabolic parameters as well as inflammatory markers. The investigators hypothesize that ST and HT will reduce HbA1c levels, improve metabolic and inflammatory profile, dysbiosis, and the anti-inflammatory heat shock response (HSR).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Jul 2023

Typical duration for not_applicable type-2-diabetes

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 11, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

1.5 years

First QC Date

April 11, 2023

Last Update Submit

May 3, 2023

Conditions

Keywords

Heat TherapyInflammationMetabolismMicrobiotaDiabetes

Outcome Measures

Primary Outcomes (1)

  • Plasma HSP72

    Plasma concentration (in ng/mL) of HSP72.

    First visit, prior to the intervention (baseline) AND 2 weeks of intervention.

Secondary Outcomes (9)

  • Fasting glucose

    First visit, prior to the intervention (baseline) AND 12 weeks of intervention.

  • Insulin plasma concentration

    First visit, prior to the intervention (baseline) AND 12 weeks of intervention.

  • Insulin resistance (HOMA-IR)

    First visit, prior to the intervention (baseline) AND 12 weeks of intervention.

  • Body Mass Index (kg·m-2)

    First visit, prior to the intervention (baseline) AND 12 weeks of intervention.

  • Visceral adipose tissue (VAT)

    First visit, prior to the intervention (baseline) AND 12 weeks of intervention.

  • +4 more secondary outcomes

Study Arms (3)

Sedentary Diabetic people

EXPERIMENTAL

Sedentary people with Type 2 Diabetes.

Other: Sedentary Control

Heat Therapy

EXPERIMENTAL

Diabetic people allocated in Heat Therapy for 12 weeks.

Other: Heat Therapy

StrengthTraining

EXPERIMENTAL

Diabetic people allocated in Strength training for 12 weeks.

Other: StrengthTraining

Interventions

Participants in the HT group will undertake whole body heat treatment according to previous methods. Participants will be housed in an environmental chamber initially set at 55.0oC on three non-consecutive days of the week during 12 weeks. Each session will last 60 min.

Heat Therapy

Participants will perform supervised exercise in a gym on three non-consecutive days of the week. Each session will last \~60 min and will consist of a warm up, the resistance training and a cool down. All sessions will be conducted by qualified sport and exercise scientists for 12 weeks.

StrengthTraining

Participants will not receive any intervention during 12 weeks.

Sedentary Diabetic people

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of type 2 diabetes
  • HbA1c levels were between 7.0% and 10%
  • Sedentary
  • Non-smoking
  • Body mass index (BMI) between 18.5-39.9 kg/m2,
  • No use of insulin.

You may not qualify if:

  • Pregnancy or breastfeeding
  • Under treatment with antibiotics or anti-inflammatory drugs within 4 weeks,
  • History of cardiovascular diseases: myocardial infarction, cardiac illness, vascular disease, stroke, or any condition that would prevent them from engaging in an exercise study;
  • Engaged in two or more planned and structured exercise sessions per week (in the last six months).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universidade Federal do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, 90040-060, Brazil

Location

Universidade Federal do Rio Grande do Sul

Porto Alegre, 90035-003, Brazil

Location

Related Publications (1)

  • Bock PM, Kowalewski LS, Ayres LR, Russo MKB, Leites GT, Martins AF, Oliveira AR, Krause M. Effect of heat therapy compared with strength training on metabolic profile, heat shock response, inflammation, cardiovascular responses and microbiota in individuals with type 2 diabetes: study protocol of a randomized trial. Sao Paulo Med J. 2025 Jun 2;143(3):e2024040. doi: 10.1590/1516-3180-2024.0040.R1.13082024. eCollection 2025.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HyperthermiaInflammationDiabetes Mellitus

Interventions

Diathermy

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsHeat Stress DisordersWounds and InjuriesPathologic Processes

Intervention Hierarchy (Ancestors)

Hyperthermia, InducedTherapeutics

Study Officials

  • Mauricio Krause, PhD

    Federal University of Rio Grande do Sul

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lucas Stahlhöfer Kowalewski, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the nature of the interventions, the researcher conducting the exercise sessions as well as participants will not be blinded. To ensure assessor masking, the subjects are asked to omit their assigned group and not to talk about their interventions during the outcome evaluation sessions. In the case of unintentional unblinding for any reason, the involved researcher will notify the principal researcher.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Volunteers who meet the inclusion criteria will be guided in the study and asked to sign a written informed consent before enrollment in the trial. Participants will be randomized into intervention groups Control (C), Resitance/Strength training (RT) or Heat Therapy (HT).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 11, 2023

First Posted

May 6, 2023

Study Start

July 1, 2023

Primary Completion

January 15, 2025

Study Completion

January 15, 2026

Last Updated

May 6, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations